# Effects Of Combination Therapy Of Statin And Ascorbic Acid For Prevention Of Contrast-Induced Nephropathy

> **NCT03391830** · NA · COMPLETED · sponsor: **Mansoura University** · enrollment: 250 (actual)

## Conditions studied

- Contrast-induced Nephropathy
- Statin
- Ascorbic Acid
- AKI

## Interventions

- **DRUG:** Atorvastatin-Ascorbic acid
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03391830
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-15
- **Primary completion:** 2020-01-01
- **Final completion:** 2020-01-01
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2021-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03391830

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03391830, "Effects Of Combination Therapy Of Statin And Ascorbic Acid For Prevention Of Contrast-Induced Nephropathy". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT03391830. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*